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Abstract 
Aims 
Cystic Echinococcosis is characterised by fluid filled hydatid cysts in the liver and 
lungs. The cysts are surrounded by a host fibrous layer (the pericyst) which acts to 
isolate the parasite from surrounding tissues. Previous studies in liver cysts have 
indicated that the parasite may be stimulating fibrosis. The aim of this study was to 
investigate whether Hydatid Cyst Fluid (HCF) could influence the potential for fibrosis 
to occur in lung tissue by stimulating epithelial to mesenchymal  transition (EMT) in a 
human lung epithelial cell line. 
Methods and Results 
An adenocarcinoma-derived alveolar basal epithelial cell line (A549) was used as a 
model for human alveolar epithelial cells (AEC II). These were cultured in vitro with 
HCF (UK sheep origin). Assays to investigate cell proliferation, cell migration and 
expression of cytoskeletal markers showed that HCF could stimulate changes indicative 
of EMT, including enhanced cell proliferation and migration; increased expression of 
mesenchymal cytoskeletal markers (fibronectin and vimentin) accompanied by a down 
regulation of an epithelial marker (E-cadherin).  
Conclusions 
Molecules within hydatid cyst fluid are capable of inducing phenotypic changes in 
A549 cells indicating that the parasite has the potential to modify lung epithelial cells 
which could contribute to fibrotic reactions.  
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Introduction 
Cystic Echinococcosis (CE) is a zoonotic infection caused by the metacestode of the 
tapeworm Echinococcus granulosus and is characterised by the development of slow 
growing hydatid cysts, mainly in the liver and lungs of domestic livestock or humans. 
The typical hydatid cyst is a unilocular fluid filled chamber which, when fertile, 
contains the protoscoleces. The hydatid cyst fluid (HCF) is a complex biological 
mixture of various soluble components including glycolipids proteins, carbohydrates 
and salts and includes host molecules as well as parasite macromolecules (including 
major diagnostic molecules, Antigen 5 (Ag5) and Antigen B (AgB)  (1-3). The fluid is 
surrounded by a cyst wall of three layers, the inner germinal layer which in turn is 
enclosed by an acellular laminated layer and surrounded by a fibrous outer layer 
(referred to as either the adventitial layer or pericyst) which is of host origin (4-7). 
The host-parasite relationship in Cystic Echinococcosis is extremely complex and cyst 
survival, growth and development is dependent on a balance between host 
immunological activity from one side, and the expression of parasite immunoevasive 
strategies from the other (5,8-10).  The fibrotic host response around the cyst is part of 
this relationship and the relative thickness of this layer can vary depending on the 
anatomical location of the cyst. In general, within animal hosts, it is most developed in 
hepatic cysts and to a lesser extent in lung cysts (11-13). It has also been suggested that 
this fibrotic activity may help in restricting growth of the cysts with lung cysts being 
perceived as having a higher growth rate than hepatic cysts (13). This suggestion is also 
supported in rare cases of brain cysts where there is little fibrosis and where very high 
growth rates have been estimated (14).  Whilst the fibrous pericyst is clearly a 
mechanism by which the host is attempting to isolate the parasite and restrict its 
development, it could also conceivably be a mechanism which is protective to the 
parasite, acting as a further barrier to potentially damaging immune effector 
mechanisms. (15-16) 
In hepatic Echinococcosis (CE and AE) the parasites are known to both upregulate and 
down regulate several hundred host genes associated with metabolism, the immune 
system (complement cascade and antigen processing) and cell signaling and transport. 
(17-20) and it has recently been shown that HCF from E. granulosus may promote 
fibrosis in hepatic stellate cells by down regulation of miR-19B (21). Similar studies 
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have not been carried out in relation to lung tissue where it might be expected that 
fibrogenic activity would be reduced. Indeed, cellular pathology and immunoregulation 
of pulmonary CE has been somewhat neglected. 
Fibrogenesis and deposition of collagen can be initiated and regulated in different 
tissues by different mechanisms. In the lungs, one such mechanism involves alveolar 
epithelial cells (AECII) which, under certain conditions, can undergo an epithelial to 
mesenchymal transition (EMT), i.e. the transformation of the epithelial cells to 
mesenchymal cells with a myofibroblast-like phenotype with subsequent hyperplasia 
that is pathognomonic for human lung fibrosis with subsequent collagen deposition (22, 
23). Epithelial cells which undergo EMT reorganize their cytoskeleton (23, 24) and 
acquire increased migratory characteristics (25, 26), accompanied by down-regulation 
of epithelial differentiation markers including E-cadherin and cytokeratin, and 
transcriptional induction of mesenchymal markers such as vimentin, fibronectin and N-
cadherin (24, 26-30).  
Parasite induced initiation of fibrogenesis in liver tissue is likely to involve a range of 
cells such as macrophages and hepatic stellate cells but there is currently no information 
on how the parasite can modify lung tissue. In order to establish whether metacestodes 
of E. granulosus are actively involved in altering the environment within the lungs 
leading to possible fibrosis, the A549 lung epithelial cell line was used to investigate 
EMT-like changes resulting from exposure to parasite-derived molecules present in 
HCF. A549 are often used in initial studies as a model for investigating effects on 
human alveolar epithelial cells type II (AECII) because they demonstrate many of the 
properties of normal lung AEC   (31,32), particularly their metabolic, structural and 
transport characteristics (25). Previous investigations into lung EMT have made use of 
this cell line and have shown it to exhibit EMT-like responses which are similar to those 
obtained with normal alveolar epithelial cells.  
 
 
Materials and methods 
Hydatid Cyst Fluid (HCF) samples 
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Samples of HCF were obtained from fertile cysts in individual naturally infected sheep 
from UK abattoirs. All samples were filter sterilized and stored frozen at -20oC until 
use. The condition of each batch of cyst fluid was assessed by checking the relative 
antigenicity of samples from different sheep by ELISA against sera from human CE 
cases and the six highest reacting samples were pooled together for use in the cell 
culture experiments (data not shown). The protein concentration of the pooled HCF 
sample was estimated using a colourimetric assay (Biorad) to be 0.18mg/ml. All 
samples were checked to be free from the presence of bacterial endotoxins using the 
ToxinSensorTM Chromogenic LAL Endotoxin Assay Kit (GenScript). 
 
Cell proliferation assay.  
A549 cells (Sigma Aldrich) were seeded at a density of 5×104 cells per well in 6 well 
plates (Falcon) and maintained in RPMI-1640 medium (Labtech International) 
supplemented with 10% foetal bovine serum FBS (Fisher Scientific), 1% L-Glutamine 
(Lonza) and 1% Penicillin-Streptomycin-Amphotericin B (Lonza), termed complete 
medium (CM). For experiments, cells were changed to serum limited medium (LSM) 
containing 0.5% FBS. Cell number and FBS concentration were optimised prior to 
finalising culture conditions (see Supplementary Data, Figs i and ii). Cells were 
incubated in 37°C incubator (Sanyo-Japan) in a humidified 5% CO2 atmosphere. 
Pooled HCF (initial concentration of 0.18mg/mL protein) was diluted 1 in 10 (18 
g/mL), 1 in 20 (9 g/mL), 1 in 50 (3.6 g/mL) and 1 in 100 (1.8 g/mL) in LSM and 
added to the plates. Cells were incubated for 120 hours with one medium change after 
72 hours. Cell growth from three replicate wells was estimated on each day using direct 
microscopic examination and a cell proliferation assessment where cell numbers were 
determined by crystal violet staining according to Chiba et al. (33). Briefly, wells were 
washed 2 times with PBS and stained with 1ml 0.1% Crystal Violet (CV) for 15 minutes 
at room temperature. The stain solution was aspirated and wells washed 3 times with 
dH2O before being allowed to air dry. 1 mL of methanol was then added to each well 
to extract the dye taken up by living cells. After 15 minutes, 100μL was transferred to 
a 96 well microtitre plate and absorbance was measured at 620nm in an Ascent 
Multiscan reader (Thermo Scientific). A calibration curve was used to relate optical 
density to estimated cell number. 
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Cell migration assay. 
Cell migration was assessed using a wound healing assay according to Liang et al. (34) 
with minor modifications. Cells were cultured in CM as described above until 70% 
confluent, then washed in LSM before a longitudinal scratch (wound) was made in the 
middle of each well using a 100µL pipette tip. HCF (18 g/mL) in LSM, or LSM alone 
was applied as a treatment. Cells were examined after 24 hours and 48 hours on an 
inverted microscope and the distance between the two sides of wound was measured at 
five equidistant points along the wound, (0.6mm between each point). 
  
EMT 
To investigate expression of EMT markers, sub-confluent A549 cells were treated with 
either 10% HCF (final protein concentration = 0.18mg/mL) in LSM, or with 5ng/mL 
TGF-β1 (PeproTech-USA) in LSM, as a known inducer of EMT (35), or LSM alone. 
Cells were cultured for a further 3 days before immunocytochemistry and microscopic 
examination. Cells were washed 2 times in PBS, fixed for 5 mins with 4% formaldehyde 
(Sigma-Aldrich), washed 2 times in PBS, then permeabilised by 1% Triton X-100 
(Sigma-Aldrich) for 5 minutes (for E-cadherin) and 0.5% Triton X-100 for 10 mins 
(Cytokeratin, Fibronectin and Vimentin), followed by 3 washes for 5 minutes with PBS. 
Non-specific binding was blocked with 3% BSA (Sigma-Aldrich) for 1 hour at room 
temperature and then cells were exposed to 1:1000 dilution (in PBS plus 1% BSA) of 
either: mouse anti-human E-cadherin (Clone HECD-1, Takara, Japan); mouse anti-
human pan cytokeratin (clone C-11, Abcam, UK); mouse anti-human fibronectin (clone 
IST-9 Abcam, UK); or mouse anti-human vimentin (Sigma-Aldrich) and incubated 
overnight at 4°C in a wet tray.  The next day, cells were washed 3 times in PBS, and 
incubated for 2 hours in the dark at room temperature with 1:2000 Alexa Fluor 546 goat 
anti-mouse IgG (Life Technologies-USA) in PBS plus 1% BSA. Cells were finally 
washed 3 times in PBS and mounted in 10µL mounting medium containing DAPI 
(Thermo Fisher Scientific) to stain cell nuclei for 1 hour. Wells were examined using 
an Eclipse TE2000-S microscope system (Nikon UK Ltd, Surrey) and Image-Pro Plus 
(Media Cybernetics UK, Berkshire).  
Semi-quantification of EMT marker expression was carried out by analysis of images 
at six fields in each well under the same image exposure conditions. The position of 
fields was chosen from a pre-defined grid pattern determined for all slides using the x-
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y co-ordinates on the microscope stage.  Cells were counted within each field, and the 
percentage of positively labelled cells (cells expressing a certain marker) calculated for 
each group. Two patterns of distribution within individual cells were sometimes evident 
and were defined as either extensive (E), throughout the whole cytoplasm or condensed 
(C) in small areas in the perinuclear region. Where these patterns were evident, the 
proportion of cells showing each pattern was also determined. 
 
 
 
Statistical analyses 
 For the cell proliferation and cell migration studies results are presented as mean values 
for three replicate wells in each treatment. Data was analysed using a paired t-test 
comparing treated and controls at each time point and for the cell proliferation study a 
one way ANOVA was also performed (IBM SPSS Statistics 20).   Each assay was 
repeated three times and similar trends were seen in all three occasions. For the cell 
marker studies counts were taken at six points in each well for three replicate wells.  A 
one way ANOVA was carried out for all treatments and all markers and also to compare 
all markers between HCF treated and control slides, and between HCF treated and TGF-
β1 treated cells. In all cases values of p < 0.05 were considered statistically significant. 
 
Results 
Cell proliferation 
There were no significant differences in proliferation between HCF treated cells and 
controls over the first 72 hours. However, from 3 to 5 days of culture there was a dose 
dependent increase in proliferation observed with HCF (Fig. 1) compared to controls 
(p < 0.001) with the highest concentration of HCF resulting in a 250% increase in cell 
number.  
     
Cell migration 
Semi-quantitative analysis of scratch assay plates showed an enhanced cell migration 
in the presence of HCF compared to control. At 24 hours, HCF-treated cells (Fig. 2A) 
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had migrated further into the “scratch” than control cells in some areas but the mean 
gap between each side of the “scratch” was not significantly different from controls 
(Fig 2B, p > 0.05).  However, at 48 hours the gap between the sides of the wound was 
closed in many areas of the HCF treated cells and the mean gap was significantly 
smaller compared to controls (Fig. 2B, p < 0.05). 
 
EMT 
Epithelial markers (Fig. 3): cells treated with HCF showed downregulation of E-
cadherin (E-Cad) expression with 40.8% positive for E-Cad in HCF treated cells, 
compared to 76.1% in controls (p < 0.01). By comparison, TGF-β1 as a known EMT 
inducer completely inhibited expression of E-Cad (Fig. 3A). Cytokeratin was 
ubiquitously expressed and there were no significant differences between treated and 
control cultures (Fig. 3B).  With respect to the intracellular distribution of expression, 
the ‘extensive’ pattern is more typical of an epithelial phenotype and although HCF 
treated cultures appeared to demonstrate fewer cells with this distribution pattern,  The 
differences in numbers did not reach significance, compared to those found in the 
control cultures (p > 0.05).  It was also noted that the staining intensity of the HCF 
treated cells was less than controls but this was not quantified. TGF-1 also did not 
reduce cytokeratin expression and had a similar pattern of staining to controls. 
Mesenchymal markers (Fig 4): cells treated with HCF showed upregulation of 
fibronectin (Fn) expression with 39.6% positive for Fn in HCF treated cells, compared 
to just 13% in controls (p < 0.01) which only weakly expressed this marker. In 
comparison, cells treated with TGF-β1 also upregulated Fn expression with 51.7% 
positive cells. Importantly, Fn expression in TGF-β1-treated cells was not statistically 
different to Fn expression in HCF treated cells, (p > 0.05). The number of cells positive 
for Vimentin (Vm) was not significantly different between HCF treated and control 
cultures (Fig. 4B), although the distribution of the marker varied. In control cells 
virtually all vimentin expression was limited to ‘condensed‘ areas in the perinuclear 
region. However, in HCF and TGF-β1 treated cultures significantly more cells showed 
more ‘extensive’ marker distribution throughout the cytoplasm (p < 0.01). However 
expression in TGF-β1 treated cells was significantly greater than in HCF treated cells 
(p < 0.05). In addition to mesenchymal marker expression, it was noted that some cells 
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in HCF treated cultures also displayed morphological features consistent with a 
mesenchymal phenotype, in producing extended cytoplasmic processes (Fig 4B). 
Statistical analysis by ANOVA indicated when all treatments and all markers were 
compared, significant differences were evident (p < 0.01). The ANOVA comparing 
HCF treated cells to controls for all markers showed significant differences (p < 0.05) 
but the differences between HCF treated cells and TGF-β1 treated cells was also 
significant (p < 0.05). 
 
Discussion 
The results of this study indicate that HCF can affect A549 cells by increasing their 
proliferation and migratory activity. In addition, exposure to HCF also alters the 
expression of some phenotypic markers i.e down regulation of epithelial markers such 
as E-cadherin and upregulation of mesenchymal markers such as fibronectin and 
vimentin. Although HCF treatment modified expression of some markers its effects 
were different from TGF-β1, a known initiator of EMT, mainly in relation to the level 
of regulation. It is also interesting to note that both treatments did not affect cytokeratin 
expression. Recent investigations note that EMT is not a binary process and cells can 
display a range of hybrid states that include but are not limited to, fully epithelial and 
fully mesenchymal, and in fact a hybrid partial EMT phenotype with cells co-
expressing markers of both epithelial and mesenchymal states has been suggested to be 
a stable phenotype that cells can adopt, depending on external factors (36). 
 
Taken together, these alterations are supportive of HCF-mediated induction of EMT. 
Although there was no significant effect on cytokeratin expression, vimentin expression 
was considered to be more extensive throughout cells, a feature which is associated 
with mesenchymal cytoskeletal reorganisation (37). These effects on A549 cells in 
themselves are not indicative of a full fibrotic reaction which would involve monitoring 
collagen deposition and other elements such as - smooth muscle actin (SMA), but 
do indicate that parasite derived molecules can lead to transformations in host cells 
which make fibrogenesis in lung tissue more likely. EMT is a frequent feature in 
patients with lung fibrosis caused by other factors. Hydatid cyst fluid from E. 
granulosus is known to have significant effects on a variety of host immune cells, from 
acting as a mitogen, non-specifically stimulating lymphocyte proliferation (38), to 
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altering accessory cell function and antigen processing (39). It has also been shown to 
modify the phenotype of cells such as monocytes (40). In most cases these effects are 
generally believed to influence the nature of the immune response in favour of parasite 
survival and often linked to a more permissive Th2 type response (8,9, 4, 42). However 
there have been no studies which have indicated that the phenotype of epithelial cells 
can be modified by HCF. The findings from this study in a lung cell line are supportive 
of the findings in LX-2 hepatic stellate cells (21) where HCF from E. granulosus has 
been shown to increase expression of α-SMA, COL1A1 and COL3A1 along with 
increased TβRII expression and inhibition of miR-19b. These authors interpretation is 
that E. granulosus metacestodes may actively promote fibrosis through the increase in 
TβRII, the activation of hepatic stellate cells and extracellular matrix production. 
 
It may be argued that the concentration of HCF used in these studies (18g/mL) is in 
excess of the true in vivo situation. HCF does leak out in large amounts, of cysts which 
have been damaged and may lead to anaphylactic reactions (43). However there are no 
definitive studies which have looked at release of cyst fluid from intact cysts. But it is 
known that antibodies to major cyst fluid antigens are present in most CE patients and 
that antibody levels may fluctuate within individuals indicating periodic release of 
antigen. Circulating cyst fluid antigens are also detectable in some CE patients (44). It 
should also be noted that HCF is a complex mixture of both host and parasite molecules 
and that the total protein concentration used in these studies will reflect all molecules 
present. The active molecules responsible for the observed effects are therefore likely 
to be present at much smaller concentrations. 
 
In the current study it is evident that there is a mechanism by which cyst fluid 
components derived from lung hydatid cysts could also promote fibrosis via EMT of 
AECII cells and subsequent differentiation into myofibroblasts. Such events would 
suggest that fibrosis is potentially beneficial for the parasite by actively stimulating the 
building of fibrous layers. The parasite recruits host cells to migrate toward the parasite 
lesion and stimulates their proliferation and transition to the fibroblast-like phenotype 
which subsequently deposits ECM components. 
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The exact molecules involved in transitional events are not known. It is valid to question 
whether or not host components may be responsible for the observed cellular changes 
in A549 cells but it is important to remember that the cell line is of human origin whilst 
the HCF will contain host molecules which are of sheep origin. In addition, proteomic 
analysis of HCF has not shown the presence of known cytokines (2, 45). Additional 
studies also indicate that HCF is not simply acting as a source of nutritional protein as 
the same proliferative effects were not evident when HCF was substituted with bovine 
serum albumen (BSA) at the same concentration. (See Supplementary Data, Fig iii). 
 
The mechanism by which HCF induces EMT is also not known. Direct stimulation of 
the cells via a ligand/receptor interaction may be possible but initiation of autocrine 
secretion of TGF-β may also be possible. With E. multilocularis infections in mice 
chronic hepatic fibrosis is a classical feature of the infection and acts to both isolate the 
parasite and contributes to pathology.  TGF- / Smad interactions are thought to be the 
driving mechanism of this process in hepatic cells, with TGF- being produced as a 
result of either parasite induced inflammation or potentially by parasite derived 
molecules which can interact with the TRI or TRII receptor (19). It is known that 
HCF contains many parasite molecules, some of which have cytokine-like properties, 
but it is interesting to note that the proliferative and migratory responses observed in 
this study were retained after heating the cyst fluid to 95oC for 5 minutes, a process that 
would affect the structural integrity of typical mammalian cytokines.  Similar activity 
was also evident in a semi-purified extract of Antigen B indicating that this known, 
heat-stable immunomodulatory molecule may have a role. (see Supplementary Data, 
Figs iv and v). 
 
Extensive fibrosis and pericyst formation in CE is often seen as a mechanism by which 
the host restricts the growth and proliferation of the metacestode. Conversley recent 
studies in experimental mice have shown that IL-17A can reduce fibrosis which leads 
to a reduced parasite biomass (46) indicating that a fibrotic reaction is favourable to the 
parasite. The thick pericyst, in addition to acting as a barrier, also provides considerable 
mechanical strength to the fluid filled cyst which may be under considerable hydrostatic 
pressure. From a transmission perspective it is important that cyst integrity is 
maintained in the natural intermediate host (domestic/wild livestock) to be available to 
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carnivorous canids. The fibrotic pericyst may therefore be essential to prevent cyst 
degeneration within the internal organs of dead livestock. This could be particularly 
important in lung cysts where the surrounding pulmonary tissue is less rigid. 
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Figure 1 
 
Fig. 1: Proliferation of A549 cells exposed to different concentrations of HCF (1.8-18 
g/mL) over 120 hours in culture. The control is medium plus 0.5% PBS. Standard 
errors (SE) are shown for the mean of three replicate wells for each treatment. All 
concentrations of HCF showed significantly more cell proliferation compared to 
controls at 96 hours (p<0.05) and 120 hours (p<0.01) but not at sample times before 
that. 
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Figure 2 
Fig. 2A: Representative views of cell migration in the “wound healing” scratch assay 
after 0, 24 and 48 hours in culture in the presence of HCF (18 g/mL)  and in control 
cultures (no HCF). Red lines represent the edge of the initial wound scratch (X100).  
Fig. 2B: Mean distance between either side of the scratch after 0 hour, 24 hour and 48 
hours of cell migration in HCF treated (18 g/mL) and control cells (no HCF). The 
results represent the mean ± SEM of 3 replicates. By 48 hours the gap in HCF treated 
cells had almost closed. The differences between treated and control cells after *24 
hours was not significant (p > 0.05) but was after 48 hours** (p < 0.01). 
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Figs. 3-4. Merged DAPI/immunofluorescence images of biomarker expression in 
A549 cells treated with HCF (18 g/mL), TGF-β1 (5ng/mL) and controls (LSM 
alone). Original magnification X400. Cell counts represent the mean ± SEM of 3 
replicate wells. 
 
Fig. 3 Panel A: E-cadherin expression. Cell counts indicate significantly less cells 
express E-cadherin in HCF treated cultures* compared to LSM controls (p < 0.01) but 
that there was significantly more expression in HCF treated cultures compared to 
TGF- β1** (p < 0.01) where no cells expressed the marker. 
Fig. 3 Panel B. cytokeratin expression.  Cell counts indicate no difference in the 
number of cells expressing cytokeratin in HCF or TGF- β1 treated cultures (p>0.05) 
compared to LSM controls (p > 0.05). Two different patterns of staining were evident; 
extensive across the whole cell (E - white arrow) and condensed around the 
perinuclear region (C – yellow arrow), but there were no significant differences in the 
proportions of cells showing either pattern although the intensity of staining in HCF 
treated cells was less than that of controls (p>0.05).  
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Fig. 4 Panel A: Fibronectin expression. Fibronectin labelling was evident in virtually 
all cells however two different patterns of staining were evident; extensive across the 
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whole cell (E - white arrow) and condensed around the perinuclear region (C – yellow 
arrow), Cell counts indicated that the extensive distribution pattern of the marker was 
significantly greater in HCF* and TGF-β1** treated cells than LSM controls (p < 0.01), 
but that there was significantly less expression in HCF treated cells than in TGF-β1 
treated cells (p < 0.05) 
Fig. 4 Panel B: Vimentin expression. Most cells in all treatments showed expression of 
vimentin, however the distribution of the marker differed. In HCF* and TGF-β1** 
treated cells the extensive staining pattern was present in significantly more cells than 
controls (p < 0.05 and p < 0.01 respectively). White arrows show the extensive type of 
vimentin expression, while yellow arrows show the condensed type of marker 
expression. Some cells also showed morphological changes involving production of 
extensive cytoplasmic processes (yellow/orange arrow). 
 
 
 
 
 
 
 
 
 
 
